factor for response to donor lymphocyte infusions in multiple myeloma The occurrence of graft-versus-host disease is the major predictive
暂无分享,去创建一个
[1] A. Barrett,et al. Review Articles (434 articles) , 2003 .
[2] Catherine J. Wu,et al. Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens. , 2004, Blood.
[3] R. Storb,et al. Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. , 2003, Blood.
[4] P. Sonneveld,et al. Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Els Goulmy,et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[6] Gienke R Boersma-Vreugdenhil,et al. Translocation of the IgH locus is nearly ubiquitous in multiple myeloma as detected by immuno-FISH. , 2003, Blood.
[7] B. van Kessel,et al. Antigens shared by malignant plasma cells and normal B cells may be involved in graft versus myeloma , 2003, Clinical and experimental immunology.
[8] M. V. van Oers,et al. Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] B. Barlogie,et al. Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. , 2000, Blood.
[10] H. Kittler,et al. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] R. Collins,et al. Donor leukocyte infusions for multiple myeloma , 2000, Bone Marrow Transplantation.
[12] S. Jagannath,et al. CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION , 1998, British journal of haematology.
[13] J. Cornelissen,et al. Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. , 1997, Blood.
[14] G. Hill,et al. Cytokine cascades in acute graft-versus-host disease. , 1997, Transplantation.
[15] B. Barlogie,et al. Graft-versus-myeloma effect: proof of principle. , 1996, Blood.
[16] R Storb,et al. Bone-marrow transplantation (second of two parts). , 1975, The New England journal of medicine.